Enneethylene glycol

Jenkem technology co ltd offers polyethylene glycol derivatives which includes y-shape (mpeg20k) 2 succinimidyl carboxymethyl ester. It can be used to produce amino groups on lysine from proteins or other biomolecules. Contact us for more information.

Jenkem technology co ltd offers monodisperse polyethylene glycol derivatives which includes amine peg12amine. Contact us for more information.

Jenkem technology co ltd offers monodisperse polyethylene glycol derivatives which includes amine peg8amine. Contact us for more information.

Jenkem technology co ltd offers monodisperse polyethylene glycol derivatives which includes carboxyl peg12carboxyl. It is a monomolecular and bifunctional peg for amine peg modification, which can be linked to lysine or n - terminal amine amine reaction. The monodisperse and bifunctional peg derivatives of...

Jenkem technology co ltd offers monodisperse polyethylene glycol derivatives which includes carboxyl peg8carboxyl. Contact us for more information.

Jenkem technology co ltd offers monodisperse polyethylene glycol derivatives which includes dodecaethylene glycol. Contact us for more information.

JenKem Technology offers large scale GMP manufacture of premium fatty acid side chain products for drug modification, with batch size of 10kg-100kg, with high purity and good lot-to-lot reproducibility. Fatty acid side chains are known to aid in improving patient compliance with increased half-life fo...

Jenkem technology co ltd offers linear polyethylene glycol derivatives which includes galactose peg succinimidyl carboxymethyl ester. It contains a carboxymethyl succinimidyl ester active gene and a galactose targeting gene, can react with amino groups of hydrophilic polyethylene glycol derivatives. Contac...

Jenkem technology co ltd offers linear polyethylene glycol derivatives which includes glucose peg succinimidyl carboxymethyl ester. It contains a carboxymethyl succinimide ester active gene and a glucose-targeted gene, which can react efficiently with amino groups in hydrophilic polyethylene glycol derivat...

Jenkem technology co ltd offers monodisperse polyethylene glycol derivatives which includes hexaethylene glycol monomethyl ether. Contact us for more information.

Jenkem technology co ltd offers monodisperse polyethylene glycol derivatives which includes hydroxyl peg12amine. It is commonly used as crosslinking agents or spacers between two different chemical substances. The peg moiety in this monomeric hetero-functional peg derivative provides water solubility and b...

Jenkem technology co ltd offers monodisperse polyethylene glycol derivatives which includes hydroxyl peg12carboxyl. It is used as crosslinking agents or spacers between two different chemical substances. The peg moiety in this monomeric heterofunctional peg derivative provides water solubility and biocompa...

JenKem Technology offers large scale GMP manufacture of premium fatty acid side chain products for drug modification, with batch size of 10kg-100kg, with high purity and good lot-to-lot reproducibility. Fatty acid side chains are known to aid in improving patient compliance with increased half-life for Glucagon-like peptide-1 (GLP-1) receptor agonists, which are extensively used in the treatment of type II diabetes and obesity. For example, several drug entities such as tirzepatide, somapacitan, or semaglutide, are modified to incorporate fatty acid side-chains.

JenKem Technology provides large scale GMP manufacture of monodisperse (discrete) PEG linkers for ADCs and for targeted protein degraders (TPD), including PROTACs, DACs, and LYTACs.

We offer a competitive price for kilogram-scale manufacture for our high-purity monodisperse PROTAC PEG linkers with various active groups, E3 ligase ligands, and E3 ligase ligand-linker conjugates, please contact us at [email protected] for a quotation.

JenKem Technology provides large scale GMP manufacture of PEG-lipids, lipids, PEG intermediates for lipid nanoparticles, along with innovative lipid nanoparticle (LNP) formulation services for selective delivery of mRNA and siRNA therapeutics.

Large scale GMP manufacture of lipids (cationic lipids, ionizable lipids, PEG lipids, phospholipids, helper lipids, SORT lipids, and others made-to-order)Development services for innovative lipids (i.e., JK-0315-CA, JK-102-CA, JK-0039, JK-0005), including lipid process development, quality research, CDE/DMF applications. Several China CDE applications and US FDA DMFs already filed for several LNP excipients
Lipid nanoparticles (LNP) formulation development, such as our innovative 3-component LNPs and 5-component LNPs for selective organ targeting
Lipid nanoparticle (LNP) encapsulation services for development of RNA therapeutics
Analytical testing services for Lipid nanoparticles (LNPs), RNA, and LNP-RNA

PEG Products Catalog